Citation: Jje. Hendriks et al., Changes in pulmonary hyperinflation and bronchial hyperresponsiveness following treatment with lansoprazole in children with cystic fibrosis, PEDIAT PULM, 31(1), 2001, pp. 59-66
Citation: Hje. Hendriks et al., Effects of therapy with lansoprazole on intestinal permeability and inflammation in young cystic fibrosis patients, J PED GASTR, 33(3), 2001, pp. 260-265
Authors:
ter Heide, H
Hendriks, HJE
Heijmans, H
Menheere, PPCA
Spaapen, LJM
Bakker, JA
Forget, PP
Citation: H. Ter Heide et al., Are children with cystic fibrosis who are treated with a proton-pump inhibitor at risk for vitamin B-12 deficiency?, J PED GASTR, 33(3), 2001, pp. 342-345
Authors:
Rubio-Gozalbo, ME
van Waardenburg, DA
Forget, PP
Spaapen, LJM
Verrips, A
Vroomen, PCAJ
Citation: Me. Rubio-gozalbo et al., Neuroleptic malignant syndrome during zuclopenthixol therapy in X-linked cerebral adrenoleukodystrophy, J INH MET D, 24(5), 2001, pp. 605-606
Authors:
Spaapen, LJM
Bakker, JA
Velter, C
Loots, W
Rubio-Gonzalbo, ME
Forget, PP
Dorland, L
De Koning, TJ
Poll-The, BT
Van Amstel, HKP
Bekhof, J
Blau, N
Duran, M
Citation: Ljm. Spaapen et al., Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Dutch neonates, J INH MET D, 24(3), 2001, pp. 352-358
Authors:
ter Steege, JCA
van de Ven, MWCM
Forget, PP
Buurman, WA
Citation: Jca. Ter Steege et al., Regulation of lipopolysaccharide-induced NO synthase expression in the major organs in a mouse model. The roles of endogenous interferon-gamma, tumornecrosis factor-alpha and interleukin-10, EUR CYTOKIN, 11(1), 2000, pp. 39-46
Authors:
Beertema, W
van Hezewijk, M
Kester, A
Forget, PP
van Kreel, B
Citation: W. Beertema et al., Measurement of total body water in children using bioelectrical impedance:A comparison of several prediction equations, J PED GASTR, 31(4), 2000, pp. 428-432
Citation: Jca. Ter Steege et al., Oral spermine administration inhibits nitric oxide-mediated intestinal damage and levels of systemic inflammatory mediators in a mouse endotoxin model, SHOCK, 11(2), 1999, pp. 115-119
Authors:
van Straaten, EA
Koster-Kamphuis, L
Bovee-Oudenhoven, IM
van der Meer, R
Forget, PP
Citation: Ea. Van Straaten et al., Increased urinary nitric oxide oxidation products in children with active coeliac disease, ACT PAEDIAT, 88(5), 1999, pp. 528-531
Authors:
Forget, PP
van Oosterhout, M
Bakker, JA
Wermuth, B
Vles, JSH
Spaapen, LJM
Citation: Pp. Forget et al., Partial N-acetyl-glutamate synthetase deficiency masquerading as a valproic acid-induced Reye-like syndrome, ACT PAEDIAT, 88(12), 1999, pp. 1409-1411
Authors:
Claeys, M
Van der Hoeven, M
de Die-Smulders, C
Bakker, JA
Offermans, JPM
Forget, PP
Groener, JEM
Spaapen, LJM
Citation: M. Claeys et al., Early-infantile type of galactosialidosis as a cause of heart failure and neonatal ascites, J INH MET D, 22(5), 1999, pp. 666-667
Citation: Fm. Schuurmans et al., Long-term growth of children with congenital heart disease: a retrospective study, ACT PAEDIAT, 87(12), 1998, pp. 1250-1255